Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P08908 (
5-HT1A
)
5,574
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Luteinizing hormone-releasing hormone (
LHRH
release, which serves as the primary drive to the hypothalamic-pituitary gonadal axis, is controlled by many neuromediators. Serotonin has been implicated in this regulation. However, it is unclear whether the central effect of serotonin on
LHRH
secretion is exerted directly on
LHRH
neurosecretory neurons or indirectly via multisynaptic pathways. The present studies were undertaken in order to examine whether
LHRH
secretion from immortalized
LHRH
cell lines is directly regulated by serotonin and, if so, to identify the receptor subtype involved. 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a
5-HT1A
/7 receptor agonist, stimulated
LHRH
release from GT1-1 cells. This effect was blocked by ritanserin, a 5-HT2/7 receptor antagonist, but not by SDZ-216-525, a
5-HT1A
antagonist. Basal
LHRH
release was not affected by the 5-HT2 agonist DOI. Reverse transcription and polymerase chain reaction technique (RT-PCR) was used in order to identify
5-HT1A
and 5-HT7 receptor mRNA in immortalized
LHRH
cell lines. GT1-1 cells express mRNA for the 5-HT7, but not the
5-HT1A
receptor subtypes. These results demonstrate a direct stimulatory effect of serotonin on
LHRH
release via 5-HT7 receptor.
...
PMID:Serotonin directly stimulates luteinizing hormone-releasing hormone release from GT1 cells via 5-HT7 receptors. 954 53